Bhullar Maneesha, Macrae Finlay, Brown Gregor, Smith Margie, Sharpe Ken
Maneesha Bhullar, Finlay Macrae, Gregor Brown, Department of Colorectal Medicine and Genetics, 3 Centre, The Royal Melbourne Hospital, Parkville 3052, Australia.
World J Gastroenterol. 2014 May 7;20(17):5008-16. doi: 10.3748/wjg.v20.i17.5008.
To investigate the association between mutations in oligomerisation domain 2/caspase recruitment domains 15 (NOD2/CARD15) and the natural history of Crohn's disease (CD) to identify patients who would benefit from early aggressive medical intervention.
We recruited thirty consecutive unrelated CD patients with a history of ileo-caecal or small bowel resection during the period 1980-2000; Fifteen patients of these had post-operative relapse that required further surgery and fifteen did not. Full sequencing of the NOD2/CARD15 gene using dHPLC for exons 3, 5, 7, 10 and 12 and direct sequencing for exons 2, 4, 6, 8, 9 and 11 was conducted. CD patients categorized as carrying variants were anyone with at least 1 variant of the NOD2/CARD15 gene.
About 13.3% of the cohort (four patients) carried at least one mutant allele of 3020insC of the NOD2/CARD15 gene. There were 20 males and 10 females with a mean age of 43.3 years (range 25-69 years). The mean follow up was 199.6 mo and a median of 189.5 mo. Sixteen sequence variations within the NOD2/CARD15 gene were identified, with 9 of them occurring with an allele frequency of greater than 10 %. In this study, there was a trend to suggest that patients with the 3020insC mutation have a higher frequency of operations compared to those without the mutation. Patients with the 3020insC mutation had a significantly shorter time between the diagnosis of CD and initial surgery. This study included Australian patients of ethnically heterogenous background unlike previous studies conducted in different countries.
These findings suggest that patients carrying NOD2/CARD15 mutations follow a rapid and more aggressive form of Crohn's disease showing a trend for multiple surgical interventions and significantly shorter time to early surgery.
研究寡聚化结构域2/半胱天冬酶募集结构域15(NOD2/CARD15)突变与克罗恩病(CD)自然病程之间的关联,以确定能从早期积极药物干预中获益的患者。
我们招募了1980年至2000年间连续30例有回盲部或小肠切除病史的无亲缘关系的CD患者;其中15例术后复发需要进一步手术,15例未复发。使用变性高效液相色谱法(dHPLC)对第3、5、7、10和12外显子进行NOD2/CARD15基因全序列分析,并对第2、4、6、8、9和11外显子进行直接测序。被归类为携带变异的CD患者是指任何携带至少1个NOD2/CARD15基因变异的患者。
该队列中约13.3%(4例患者)携带NOD2/CARD15基因3020insC的至少1个突变等位基因。有20名男性和10名女性,平均年龄43.3岁(范围25 - 69岁)。平均随访时间为199.6个月,中位数为189.5个月。在NOD2/CARD15基因内鉴定出16个序列变异,其中9个的等位基因频率大于10%。在本研究中,有趋势表明与无3020insC突变的患者相比,有该突变的患者手术频率更高。有3020insC突变的患者在CD诊断至初次手术之间的时间明显更短。与之前在不同国家进行的研究不同,本研究纳入了具有不同种族背景的澳大利亚患者。
这些发现表明,携带NOD2/CARD15突变的患者患有一种快速且更具侵袭性的克罗恩病形式,表现出多次手术干预的趋势,且至早期手术的时间明显更短。